Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2

VANCOUVER, British Columbia, Dec. 08, 2021 -- Algernon Pharmaceuticals Inc.Β (the β€œCompany” or β€œAlgernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (β€œcGMP”) of AP-188 (β€œN,N-Dimethyltryptamine or ... Read More...